-
Mashup Score: 0News - Practical Neurology - 7 month(s) ago
Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and…
Source: practicalneurology.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Background: Resolution of inflammation is orchestrated by specialized proresolving lipid mediators (SPMs), and this would be impaired in some cardiovascular diseases. Among SPMs, resolvins (Rv) have
Source: HypertensionCategories: Cardiology News and Journals, Latest HeadlinesTweet-
EDITORS PICK: In @HyperAHA, Briones' lab @InflavasFarmaL4 shows that the proresolvin lipid mediator Resolvin D2 prevents and regresses #Cardiovascular damage and inflammation in hypertensive mice #SPMs #Hypertension @jdallilab https://t.co/ZfRYGoFNzr https://t.co/t20iPiTZEO
-
-
Mashup Score: 5Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Via @ANA_journals: Cervical cord atrophy is an early indicator that #MultipleSclerosis will lead to #SPMS. Drs. @DeSilvaTara, @DrTarunSinghal, Keegan say it could help determine therapeutic options earlier. https://t.co/pHvQ5CZbUI #MultipleSclerosisAwareness #NeuroTwitter https://t.co/mKs8Xf9yck
-
-
Mashup Score: 6Wolters Kluwer Health - 2 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable…
Source: lww.comCategories: Latest Headlines, NeurologyTweet-
Via @ANA_journals: researchers at @UCFS found that cervical cord atrophy is an early indicator that #MultipleSclerosis will lead to #SPMS. Drs. @DeSilvaTara, @DrTarunSinghal, Keegan say it could help determine prognosis and therapeutic options earlier. https://t.co/pHvQ5CZbUI https://t.co/ukI0t7oWeh
-
-
Mashup Score: 4
Rationale: Resolution mechanisms are central in both the maintenance of homeostasis and the return to catabasis following tissue injury and infections. Among the proresolving mediators, the essential
Source: Circulation ResearchCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Koenis & colleagues found that specialized #SPMs limit the inflammatory response following #COVID-19 but fail in patients with severe COVID-19 #pneumonia. Learn how #dexamethasone promotes resolution of #inflammation https://t.co/ca16LNAh3b @honglu227 @QMULWHRI @QMUL https://t.co/4O2odxyhlN
-
-
Mashup Score: 2Effects of High and Low Efficacy Therapy in Secondary Progressive Multiple Sclerosis - 3 year(s) ago
Objective: To compare the clinical effectiveness of high- and low-efficacy treatments in patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) after accounting for therapeutic lag. Methods: Patients treated with high- (natalizumab, alemtuzumab, mitoxantrone, ocrelizumab, rituximab, cladribine, fingolimod) or low-efficacy (interferon β, glatiramer acetate,…
Source: NeurologyCategories: Latest Headlines, NeurologyTweet-
Via @GreenJournal: In pts w/active secondary progressive #multiplesclerosis (#SPMS), high efficacy therapy was better than low-efficacy therapy in lowering relapses. However, this trend did not occur in pts/winactive SPMS.#NeuroTwitter #neurology https://t.co/LBSPg8EyBd https://t.co/Wk9r4Vy8EN
-
Data from #DanishMSRegistry reveal patterns and predictors of conversion from #RRMS to #SPMS #MultipleSclerosis, in study from #MSMilan2023 @ECTRIMS @ACTRIMS.https://t.co/1yLxXnxmLE